- Home
- BTGO vs NBTX Comparison
BTGO vs NBTX Comparison
Compare BTGO & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTGO | NBTX |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | United States | France |
| Employees | 603 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 961.8M | 1.0B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | BTGO | NBTX |
|---|---|---|
| Price | $11.92 | $48.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $14.83 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 501.1K | 62.8K |
| Earning Date | 05-13-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $58.17 |
| Revenue Next Year | $34.41 | N/A |
| P/E Ratio | $10.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.25 | $3.64 |
| 52 Week High | $15.30 | $54.74 |
Technical Indicators
Market Signals| Indicator | BTGO | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.19 | 66.18 |
| Support Level | $9.62 | $20.11 |
| Resistance Level | $12.11 | N/A |
| Average True Range (ATR) | 0.77 | 2.71 |
| MACD | 0.17 | 1.76 |
| Stochastic Oscillator | 67.11 | 71.11 |
Price Performance
Historical ComparisonAbout BTGO BitGo Holdings Inc. Class A Common Stock
BitGo Holdings Inc provides various offerings to its clients including multi-signature blockchain wallet solutions allowing for secure storage, trade settlement, staking solutions, and lending of digital assets. The Company also provides professional services to develop smart contracts. Its clients range from crypto-native companies that use its self-custody wallet technology to traditional financial services firms that leverage its licensed custody, staking and trading capabilities within their own products and services.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.